Gene-expression data have revealed downregulation of the OLFM4 gene in prostate cancer, colon cancer, and leukemia, whereas OLFM4 expression was found to be upregulated in gastric cancer and pancreatic cancer. This evidence concerns the gene OLFM4 and prostate carcinoma.